What does CUSIP 629444100 represent in this 13F holders report?

CUSIP 629444100 is the security identifier for NRXP - NRX PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held NRXP - NRX PHARMACEUTICALS INC - COM in Q2 2023?

32 institutional investors reported NRXP - NRX PHARMACEUTICALS INC - COM for Q2 2023. Use the holders table for investor-level position and value details.

NRX PHARMACEUTICALS INC - COM (NRXP)

CUSIP: 629444100

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / COM
Total 13F shares: 9,891,867
Total 13F value: $4,781,756
Share change: +6,744,175
Put/Call ratio: 4.3%
SEC-reported price per share: $0.48
Number of holders: 32
Value change: +$3,238,749
Number of buys: 12
Number of sells: 8

Security key

629444100

Report period

Q2 2023

Institutions

Top holders

NRXP full security history Ownership snapshot Full 13F holder table NRX Pharmaceuticals, Inc. SEC filings NRX Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NRXP - NRX PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Daniel C. Javitt

Disclosed value leader

Daniel C. Javitt

Comparable rows

0/15

Latest evidence

31 Mar 2023

3/4/5 13F Highest disclosed value: $3,082,170 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Daniel C. Javitt has the largest disclosed position value at $3.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Daniel C. Javitt's linked filing trail.

Disclosed position value Top 5

Daniel C. Javitt $3.08M

BRAC Lending Group LLC $188.9K

Big Rock Partners Sponsor, LLC $166.1K

VANGUARD GROUP INC $974.2K

GEODE CAPITAL MANAGEMENT, LLC $249.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Daniel C. Javitt	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,082,170 9,634,793 shares	—	29 Nov 2022
BRAC Lending Group LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$188,880 590,435 shares	—	24 May 2021
Big Rock Partners Sponsor, LLC	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$166,129 619,315 shares mixed-class rows	—	24 May 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$974,250 1,478,153 shares	—	31 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$249,579 378,667 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$247,325 375,247 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,891,867

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %